Last reviewed · How we verify

NCT06249217: GNSP

Good Nights Sleep Program to Improve Child and Family Sleep

Active, enrolled Phase 1, PHASE2 Last updated 23 August 2024
What this trial tests

Phase 1, PHASE2 trial testing Good Nights Sleep Program in Sleep Problems in 60 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 February 2024
Primary endpoint
1 September 2024
1 October 2024

Quick facts

Lead sponsorAuburn University
PhasePhase 1, PHASE2
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date1 February 2024
Primary completion1 September 2024
Estimated completion1 October 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Auburn University

Who can join

Adults 7 to 10, any sex, with Sleep Problems or Sleep Hygiene. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to pilot a randomized clinical trial designed to improve the sleep environments, sleep hygiene practices, and the duration and quality of sleep of children and parents in low-income families. It is hypothesized that child and parent sleep (assessed through subjective reports of sleep, sleep environments, sleep hygiene practices, and objective sleep data via sleep actigraphy collected with Fitbit watches) in the intervention group will improve between Week 2 (intervention session) and Week 4 (post-intervention session) as compared to child and parent sleep in the waitlist-control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sleep Problems

Currently open trials in the same condition.

Other Auburn University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06249217.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing